Aarti Drugs Limited has announced its audited standalone and consolidated financial results for the quarter ended June 30, 2026. The company reported a standalone profit of ₹5,085 lakhs. The Board of Directors approved these results, which reflect revenue from operations of ₹62,745 lakhs and total expenses of ₹55,771 lakhs for the standalone entity. The consolidated figures also showed positive performance, with total income at ₹70,359 lakhs and a profit of ₹5,013 lakhs.
Aarti Drugs Reports Strong Q1 FY27 Results
Aarti Drugs Limited has officially released its audited standalone and consolidated financial results for the first quarter of the financial year 2026-27, ending on June 30, 2026. The Board of Directors reviewed and approved these results during a meeting held on July 31, 2026.
Standalone Financial Performance
For the standalone entity, the company generated revenue from operations amounting to ₹62,745 lakhs. With other income contributing a small portion, the total income stood at ₹62,765 lakhs. Total expenses for the quarter were reported at ₹55,771 lakhs. This resulted in a profit before exceptional items and tax of ₹6,994 lakhs. After accounting for tax expenses of ₹1,700 lakhs, the net profit for the quarter (Profit/Loss for the Year) was ₹5,085 lakhs. The total comprehensive income for the year also stood at ₹5,085 lakhs.
Consolidated Financial Performance
On a consolidated basis, which includes its subsidiaries, Aarti Drugs reported revenue from operations of ₹70,278 lakhs and total income of ₹70,359 lakhs. Total expenses for the consolidated entity were ₹63,226 lakhs. The profit before exceptional items and tax was ₹7,132 lakhs. After tax expenses of ₹1,911 lakhs, the consolidated profit for the quarter was ₹5,013 lakhs. The total comprehensive income for the consolidated entity for the quarter was ₹5,019 lakhs.
Key Financial Metrics
The earnings per equity share (EPS) for the standalone results were ₹5.57 (basic and diluted). For the consolidated results, the basic and diluted EPS stood at ₹5.49.
Auditor’s Report and Disclosures
The company has also provided the Auditor’s Report on the Financial Results, confirming an unmodified audit opinion for both standalone and consolidated statements. The financial results will be published in newspapers and uploaded on the company’s website, www.aartidrugs.com, as well as on the websites of the BSE Limited and the National Stock Exchange of India Limited.
Source: BSE
